Balchem (BCPC) Expected to Announce Quarterly Earnings on Friday

Balchem (NASDAQ:BCPC) is anticipated to issue its quarterly earnings data before the market opens on Friday, February 21st. Analysts expect the company to announce earnings of $1.11 per share and revenue of $239.96 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Balchem Price Performance

BCPC stock opened at $163.78 on Thursday. The firm has a 50 day moving average of $162.76 and a 200-day moving average of $169.38. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. Balchem has a 12 month low of $137.69 and a 12 month high of $186.03. The firm has a market capitalization of $5.32 billion, a P/E ratio of 44.03, a price-to-earnings-growth ratio of 4.61 and a beta of 0.69.

Balchem Increases Dividend

The company also recently declared an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were issued a $0.87 dividend. This represents a yield of 0.4%. This is an increase from Balchem’s previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. Balchem’s dividend payout ratio (DPR) is presently 23.39%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright lifted their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.